Found: 138
Select item for more details and to access through your institution.
FUS-ERG gene fusion in isolated myeloid sarcoma showing uncommon clinical features.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Recent advances and future perspectives of T-cell engagers in lymphoid malignancies.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 4, p. 376, doi. 10.1093/jjco/hyad186
- By:
- Publication type:
- Article
An update on the developments in the treatment of adult T-cell leukemia–lymphoma: current knowledge and future perspective.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 12, p. 1104, doi. 10.1093/jjco/hyad108
- By:
- Publication type:
- Article
Randomized phase III study of daratumumab versus bortezomib plus daratumumab as maintenance therapy after D-MPB for transplant-ineligible patients with untreated multiple myeloma (JCOG1911, B-DASH study).
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 4, p. 349, doi. 10.1093/jjco/hyac198
- By:
- Publication type:
- Article
Recent advances in the management of older adults with newly diagnosed multiple myeloma in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 9, p. 966, doi. 10.1093/jjco/hyac111
- By:
- Publication type:
- Article
Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 583, doi. 10.1093/jjco/hyac039
- By:
- Publication type:
- Article
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 7, p. 1059, doi. 10.1093/jjco/hyab066
- By:
- Publication type:
- Article
Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 70, doi. 10.1093/jjco/hyaa169
- By:
- Publication type:
- Article
Final results of a phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 11, p. 1265, doi. 10.1093/jjco/hyaa117
- By:
- Publication type:
- Article
Revised staging system for malignant lymphoma based on the Lugano classification.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 10, p. 895, doi. 10.1093/jjco/hyz111
- By:
- Publication type:
- Article
Phase III study of watchful waiting vs. rituximab as first-line treatment in advanced stage follicular lymphoma with low tumour burden (JCOG1411, FLORA study).
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 8, p. 777, doi. 10.1093/jjco/hyy085
- By:
- Publication type:
- Article
Atypical radiological presentation of pulmonary invasion of diffuse large B-cell lymphoma mimicking Pneumocystis jiroveci pneumonia.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 3, p. 298, doi. 10.1093/jjco/hyx194
- By:
- Publication type:
- Article
Clinicopathological features of classical Hodgkin lymphoma in patients ≥ 40 years old, with special reference to composite cases.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 10, p. 921, doi. 10.1093/jjco/hyv101
- By:
- Publication type:
- Article
Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997-2016.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinicopathological prognostic factors of 24 patients with B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma.
- Published in:
- International Journal of Hematology, 2015, v. 101, n. 3, p. 286, doi. 10.1007/s12185-015-1743-y
- By:
- Publication type:
- Article
Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Nocardia exalbida brain abscess in a patient with follicular lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Extramedullary Plasmacytoma Mimicking Gallbladder Cancer.
- Published in:
- Internal Medicine, 2023, v. 62, n. 17, p. 2581, doi. 10.2169/internalmedicine.1079-22
- By:
- Publication type:
- Article
R‐CHOP treatment for patients with advanced follicular lymphoma: Over 15‐year follow‐up of JCOG0203.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 849, doi. 10.1111/bjh.19213
- By:
- Publication type:
- Article
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 531, doi. 10.1111/bjh.16878
- By:
- Publication type:
- Article
Acute megakaryoblastic leukaemia with t(1;22)(p13·3;q13·1)/RBM15‐MKL1 in an adult patient following a non‐mediastinal germ cell tumour.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. e329, doi. 10.1111/bjh.16900
- By:
- Publication type:
- Article
Bone marrow involvement by monomorphic epitheliotropic intestinal T‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 1, p. 10, doi. 10.1111/bjh.16073
- By:
- Publication type:
- Article
Possibility of a risk‐adapted treatment strategy for untreated aggressive adult T‐cell leukaemia‐lymphoma (ATL) based on the ATL prognostic index: a supplementary analysis of the JCOG9801.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. 440, doi. 10.1111/bjh.15950
- By:
- Publication type:
- Article
Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 6, p. 923, doi. 10.1111/bjh.14153
- By:
- Publication type:
- Article
Incidental detection of malignant lymphoma in subjects in a cancer surveillance programme.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 1, p. 138, doi. 10.1111/bjh.13178
- By:
- Publication type:
- Article
A comparison of clinical staging using the Lugano versus Ann Arbor classifications in Japanese patients with Hodgkin lymphoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 3, p. 108, doi. 10.1111/ajco.13248
- By:
- Publication type:
- Article
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 899, doi. 10.1007/s10147-023-02461-4
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1081, doi. 10.1007/s10147-024-02572-6
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1074, doi. 10.1007/s10147-024-02570-8
- By:
- Publication type:
- Article
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1067, doi. 10.1007/s10147-024-02569-1
- By:
- Publication type:
- Article
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 681, doi. 10.1007/s10147-024-02504-4
- By:
- Publication type:
- Article
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 700, doi. 10.1007/s10147-024-02541-z
- By:
- Publication type:
- Article
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 689, doi. 10.1007/s10147-024-02502-6
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 559, doi. 10.1007/s10147-024-02501-7
- By:
- Publication type:
- Article
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 551, doi. 10.1007/s10147-024-02499-y
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 545, doi. 10.1007/s10147-024-02491-6
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 535, doi. 10.1007/s10147-023-02465-0
- By:
- Publication type:
- Article
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 355, doi. 10.1007/s10147-024-02469-4
- By:
- Publication type:
- Article
Comparison of the International Workshop Criteria and the Response Evaluation Criteria in Solid Tumors for indolent B-cell lymphoma.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 429, doi. 10.1007/s10147-020-01800-z
- By:
- Publication type:
- Article
Diagnostic utility and prognostic significance of the Ki‐67 labeling index in diffuse large B‐cell lymphoma transformed from follicular lymphoma: a study of 76 patients.
- Published in:
- Pathology International, 2021, v. 71, n. 10, p. 674, doi. 10.1111/pin.13148
- By:
- Publication type:
- Article
EBV‐encoded RNA1‐positive cells in the bone marrow specimens of patients with EBV‐negative lymphomas and sarcomas.
- Published in:
- Pathology International, 2019, v. 69, n. 7, p. 392, doi. 10.1111/pin.12825
- By:
- Publication type:
- Article